NSE: THYROCARE | BSE: 539871

Mid-range Performer

Download real time

1199.50 -6.80 (-0.56%)

82.29% Gain from 52W Low

31,652 NSE+BSE Volume

NSE 25 Sep, 2025 3:31 PM (IST)

6,356.7

Market Cap

High in industry

0.3

Beta 1Year

Very Low volatility

Thyrocare Technologies Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for THYROCARE, BSE:539871 Thyrocare Technologies Ltd.

Thyrocare Technologies Ltd.

16 Aug 2016

1199.50

-0.56%

Pick of the Week - Thyrocare Technologies Ltd

Buy: Thyrocare Technologies Ltd.

HDFC Securities

BUY Thyrocare Technologies Ltd on Declines Between Rs. 520 - Rs. 490 for the target of Rs. 625 - Rs. 710

Number of FII/FPI investors increased from 80 to 99 in Jun 2025 qtr.

Thyrocare Technologies Ltd.

27 Apr 2016

1199.50

-0.56%

IPO Note - Thyrocare Technologies ltd

IPO Note: Thyrocare Technologies Ltd.

Aditya Birla Money Limited

Strong operating performance and asset light model leading to high returns: The franchise model of the company has helped it to minimize its capital expenditure leading to higher returns on equity as well as return on capital employed. TTL's sales...

Thyrocare Technologies Ltd. is trading below its 30 day SMA of 1284.2

Thyrocare Technologies Ltd.

27 Apr 2016

1199.50

-0.56%

Thyrocare IPO note 27Apr2016

Thyrocare Technologies Ltd.

Phillip Capital

chains. It has a leadership position in (the fastest growing and highest valueadded) diagnosticserviceofferingsinwellnessandpreventivecarethismakesitanindustryleader inprofitability.Weexpectittodeliverrevenue/PATCAGRof25%/29%overFY1518.Atthe...

Thyrocare Technologi.. has an average target of 1000.00 from 1 broker.

Thyrocare Technologies Ltd.

27 Apr 2016

1199.50

-0.56%

Thyrocare Technologies IPO Note

Thyrocare Technologies Ltd.

BOB Capital Markets Ltd.

The company is a provider of diagnostic and related healthcare tests and services in India and is specialised in preventive and wellness segment of the diagnostics industry which has broader scope to grow with improving life style...

Number of FII/FPI investors increased from 80 to 99 in Jun 2025 qtr.

Thyrocare Technologies Ltd.

26 Apr 2016

1199.50

-0.56%

Thyrocare Technologies Limited

Thyrocare Technologies Ltd.

Angel Broking

Thyrocare Technologies is one of the leading diagnostic chains in India with market share of ~3% amongst organised players. The core business of the company is diagnostic testing (~97.1% of sales as on 9MFY2016) while the company through its wholly owned subsidiary also operates imaging centres. A differentiated model enables higher margi..

Thyrocare Technologies Ltd. is trading below its 30 day SMA of 1284.2

Is Thyrocare Technologies Ltd. worth buying?

169 Votes:

Buy 77.51%

Sell 11.83%

Hold 10.65%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf